Skip to main content
×
Home
    • Aa
    • Aa
  • Get access
    Check if you have access via personal or institutional login
  • Cited by 51
  • Cited by
    This article has been cited by the following publications. This list is generated based on data provided by CrossRef.

    Abo El Gheit, Rehab E. 2016. Combined calcitonin gene-related peptide receptor antagonist, MK-8825, and caffeine as potential therapeutic target in the nitroglycerin-induced rat migraine model (MK-8825 and caffeine in migraine). Alexandria Journal of Medicine,


    Afrin, Lawrence B. 2016. Mast cell activation disease and the modern epidemic of chronic inflammatory disease. Translational Research, Vol. 174, p. 33.


    Dux, Mária Deák, Éva Tassi, Noémi Sántha, Péter and Jancsó, Gábor 2016. Endovanilloids are potential activators of the trigeminovascular nocisensor complex. The Journal of Headache and Pain, Vol. 17, Issue. 1,


    Giamberardino, Maria Adele Affaitati, Giannapia Curto, Martina Negro, Andrea Costantini, Raffaele and Martelletti, Paolo 2016. Anti-CGRP monoclonal antibodies in migraine: current perspectives. Internal and Emergency Medicine,


    Miller, Silke Liu, Hantao Warfvinge, Karin Shi, Licheng Dovlatyan, Mary Xu, Cen and Edvinsson, Lars 2016. Immunohistochemical localization of the calcitonin gene-related peptide binding site in the primate trigeminovascular system using functional antagonist antibodies. Neuroscience, Vol. 328, p. 165.


    Mirsane, Sayed Alireza and Shafagh, Shima 2016. Effects of Helicobacter pylori Infection and Western Diet on Migraine. Gene, Cell and Tissue, Vol. Inpress, Issue. Inpress,


    Negro, Andrea Curto, Martina Lionetto, Luana Giamberardino, Maria Adele and Martelletti, Paolo 2016. Chronic migraine treatment: from OnabotulinumtoxinA onwards. Expert Review of Neurotherapeutics, p. 1.


    Ramroodi, Nourollah Javan, Mohammad Reza Sanadgol, Nima Jahantigh, Mehdi Nakhzari Khodakheir, Tooba and Ranjbar, Nasrin 2016. Association between interleukin-4 (IL-4), gene polymorphisms (C-589T, T+2979G, and C-33T) and migraine susceptibility in Iranian population: A case–control study. Egyptian Journal of Medical Human Genetics,


    Bigal, Marcelo E Edvinsson, Lars Rapoport, Alan M Lipton, Richard B Spierings, Egilius L H Diener, Hans-Christoph Burstein, Rami Loupe, Pippa S Ma, Yuju Yang, Ronghua and Silberstein, Stephen D 2015. Safety, tolerability, and efficacy of TEV-48125 for preventive treatment of chronic migraine: a multicentre, randomised, double-blind, placebo-controlled, phase 2b study. The Lancet Neurology, Vol. 14, Issue. 11, p. 1091.


    Buntinx, Linde Vermeersch, Steve and de Hoon, Jan 2015. Development of anti-migraine therapeutics using the capsaicin-induced dermal blood flow model. British Journal of Clinical Pharmacology, Vol. 80, Issue. 5, p. 992.


    Carreira, Ricardo J. Shyti, Reinald Balluff, Benjamin Abdelmoula, Walid M. van Heiningen, Sandra H. van Zeijl, Rene J. Dijkstra, Jouke Ferrari, Michel D. Tolner, Else A. McDonnell, Liam A. and van den Maagdenberg, Arn M. J. M. 2015. Large-Scale Mass Spectrometry Imaging Investigation of Consequences of Cortical Spreading Depression in a Transgenic Mouse Model of Migraine. Journal of The American Society for Mass Spectrometry, Vol. 26, Issue. 6, p. 853.


    Di, W. Zheng, Z.-Y. Xiao, Z.-J. Qi, W.-W. Shi, X.-L. Luo, N. Lin, J.-W. Ding, M.-H. Zhang, A.-W. and Fang, Y.-N. 2015. Pregabalin alleviates the nitroglycerin-induced hyperalgesia in rats. Neuroscience, Vol. 284, p. 11.


    Duarte, Halina Teixeira, Antonio L. Rocha, Natália P. and Domingues, Renan B. 2015. Increased interictal serum levels of CXCL8/IL-8 and CCL3/MIP-1α in migraine. Neurological Sciences, Vol. 36, Issue. 2, p. 203.


    Eftekhari, Sajedeh Salvatore, Christopher A. Johansson, Sara Chen, Tsing-bau Zeng, Zhizhen and Edvinsson, Lars 2015. Localization of CGRP, CGRP receptor, PACAP and glutamate in trigeminal ganglion. Relation to the blood–brain barrier. Brain Research, Vol. 1600, p. 93.


    Gonzalez, Eric J. Peterson, Abbey Malley, Susan Daniel, Mitchel Lambert, Daniel Kosofsky, Michael and Vizzard, Margaret A. 2015. The Effects of Tempol on Cyclophosphamide-Induced Oxidative Stress in Rat Micturition Reflexes. The Scientific World Journal, Vol. 2015, p. 1.


    Javed, Fawad Al-Kheraif, AbdulAziz A. Romanos, Enisa B. and Romanos, Georgios E. 2015. Influence of orthodontic forces on human dental pulp: A systematic review. Archives of Oral Biology, Vol. 60, Issue. 2, p. 347.


    Karsan, Nazia and Goadsby, Peter J. 2015. Calcitonin gene-related peptide and migraine. Current Opinion in Neurology, Vol. 28, Issue. 3, p. 250.


    Laux-Biehlmann, Alexis d’Hooghe, Thomas and Zollner, Thomas M. 2015. Menstruation pulls the trigger for inflammation and pain in endometriosis. Trends in Pharmacological Sciences, Vol. 36, Issue. 5, p. 270.


    Li, Chi-Chung Vermeersch, Steve Denney, William S. Kennedy, William P. Palcza, John Gipson, Adrianna Han, Tae H. Blanchard, Rebecca De Lepeleire, Inge Depré, Marleen Murphy, M. Gail Van Dyck, Kristien and de Hoon, Jan N. 2015. Characterizing the PK/PD relationship for inhibition of capsaicin-induced dermal vasodilatation by MK-3207, an oral calcitonin gene related peptide receptor antagonist. British Journal of Clinical Pharmacology, Vol. 79, Issue. 5, p. 831.


    Lucas, Sylvia 2015. Headache and Migraine Biology and Management.


    ×
  • Expert Reviews in Molecular Medicine, Volume 13
  • 2011, e36

Calcitonin gene-related peptide in migraine: intersection of peripheral inflammation and central modulation

  • Ann C. Raddant (a1) and Andrew F. Russo (a1)
  • DOI: http://dx.doi.org/10.1017/S1462399411002067
  • Published online: 29 November 2011
Abstract

Over the past two decades, a convergence of basic and clinical evidence has established the neuropeptide calcitonin-gene-related peptide (CGRP) as a key player in migraine. Although CGRP is a recognised neuromodulator of nociception, its mechanism of action in migraine remains elusive. In this review, we present evidence that led us to propose that CGRP is well poised to enhance neurotransmission in migraine by both peripheral and central mechanisms. In the periphery, it is thought that local release of CGRP from the nerve endings of meningeal nociceptors following their initial activation by cortical spreading depression is critical for the induction of vasodilation, plasma protein extravasation, neurogenic inflammation and the consequential sensitisation of meningeal nociceptors. Mechanistically, we propose that CGRP release can give rise to a positive-feedback loop involved in localised increased synthesis and release of CGRP from neurons and a CGRP-like peptide called procalcitonin from trigeminal ganglion glia. Within the brain, the wide distribution of CGRP and CGRP receptors provides numerous possible targets for CGRP to act as a neuromodulator.

Copyright
Corresponding author
*Corresponding author: Andrew F. Russo. E-mail: andrew-russo@uiowa.edu
Linked references
Hide All

This list contains references from the content that can be linked to their source. For a full set of references and notes please see the PDF or HTML where available.

1D. Pietrobon and J. Striessnig (2003) Neurobiology of migraine. Nature Reviews Neuroscience 4, 386-398

3S.J. Wimalawansa (1996) Calcitonin gene-related peptide and its receptors: molecular genetics, physiology, pathophysiology, and therapeutic potentials. Endocrine Reviews 17, 533-585

4D. van Rossum , U.K. Hanisch and R. Quirion (1997) Neuroanatomical localization, pharmacological characterization and functions of CGRP, related peptides and their receptors. Neuroscience & Biobehavioral Reviews 21, 649-678

5A.F. Russo and I.M. Dickerson (2006) CGRP: A multifunctional neuropeptide. In Handboook Neurochem Molec Neurobiol (3rd edn) A. Lajtha , ed.), pp. 391-426, Springer, New York, NY

6A. Recober and A.F. Russo (2009) Calcitonin gene-related peptide: an update on the biology. Current Opinion in Neurology 22, 241-246

7J. Tajti (1999) Messenger molecules and receptor mRNA in the human trigeminal ganglion. Journal of the Autonomic Nervous System 76, 176-183

8S. Eftekhari (2010) Differential distribution of calcitonin gene-related peptide and its receptor components in the human trigeminal ganglion. Neuroscience 169, 683-696

9K. Messlinger (2009) Migraine: where and how does the pain originate? Experimental Brain Research 196, 179-193

10K. Messlinger (1993) Innervation of the dura mater encephali of cat and rat: ultrastructure and calcitonin gene-related peptide-like and substance P-like immunoreactivity. Anatomy and Embryology (Berlin) 188, 219-237

11Y. Liu , J. Broman and L. Edvinsson (2008) Central projections of the sensory innervation of the rat middle meningeal artery. Brain Research 1208, 103-110

12S.D. Brain and A.D. Grant (2004) Vascular actions of calcitonin gene-related peptide and adrenomedullin. Physiological Reviews 84, 903-934

13L. Edvinsson (2002) Effect of the CGRP receptor antagonist BIBN4096BS in human cerebral, coronary and omental arteries and in SK-N-MC cells. European Journal of Pharmacology 434, 49-53

14M.J. Moreno (2002) Efficacy of the non-peptide CGRP receptor antagonist BIBN4096BS in blocking CGRP-induced dilations in human and bovine cerebral arteries: potential implications in acute migraine treatment. Neuropharmacology 42, 568-576

16A. Ottosson and L. Edvinsson (1997) Release of histamine from dural mast cells by substance P and calcitonin gene-related peptide. Cephalalgia 17, 166-174

17T.C. Theoharides (2005) The role of mast cells in migraine pathophysiology. Brain Research and Brain Research Reviews 49, 65-76

18G. Skofitsch and D.M. Jacobowitz (1985) Calcitonin gene-related peptide coexists with substance P in capsaicin sensitive neurons and sensory ganglia of the rat. Peptides 6, 747-754

19J.M. Lundberg (1985) Co-existence of substance P and calcitonin gene-related peptide-like immunoreactivities in sensory nerves in relation to cardiovascular and bronchoconstrictor effects of capsaicin. European Journal of Pharmacology 108, 315-319

20Y. Lee (1985) Distribution of calcitonin gene-related peptide in the rat peripheral nervous system with reference to its coexistence with substance P. Neuroscience 15, 1227-1237

21J.K. Lennerz (2008) Calcitonin receptor-like receptor (CLR), receptor activity-modifying protein 1 (RAMP1), and calcitonin gene-related peptide (CGRP) immunoreactivity in the rat trigeminovascular system: differences between peripheral and central CGRP receptor distribution. Journal of Comparative Neurology 507, 1277-1299

22M.J. Fischer (2010) Calcitonin gene-related peptide receptor antagonists for migraine. Expert Opinion on Investigational Drugs 19, 815-823

23B. Marquez de Prado , D.L. Hammond and A.F Russo . (2009) Genetic enhancement of calcitonin gene-related peptide-induced central sensitization to mechanical stimuli in mice. Journal of Pain 10, 992-1000

24R.J. Storer , S. Akerman and P.J. Goadsby (2004) Calcitonin gene-related peptide (CGRP) modulates nociceptive trigeminovascular transmission in the cat. British Journal of Pharmacology 142, 1171-1181

25M.J. Fischer , S. Koulchitsky and K. Messlinger (2005) The nonpeptide calcitonin gene-related peptide receptor antagonist BIBN4096BS lowers the activity of neurons with meningeal input in the rat spinal trigeminal nucleus. Journal of Neuroscience 25, 5877-5883

26D. Levy , R. Burstein and A.M. Strassman (2005) Calcitonin gene-related peptide does not excite or sensitize meningeal nociceptors: implications for the pathophysiology of migraine. Annals of Neurology 58, 698-705

27J.K. Archbold (2011) Structural insights into RAMP modification of secretin family G protein-coupled receptors: implications for drug development. Trends in Pharmacological Sciences 32, 591-600

29B.N. Evans (2000) CGRP-RCP, a novel protein required for signal transduction at calcitonin gene-related peptide and adrenomedullin receptors. Journal of Biological Chemistry 275, 31438-31443

31Z. Zhang , I.M. Dickerson and A.F. Russo (2006) Calcitonin gene-related peptide receptor activation by receptor activity-modifying protein-1 gene transfer to vascular smooth muscle cells. Endocrinology 147, 1932-1940

32A.F. Russo (2007) Ramping it up: RAMP1 and the implications for migraine. Pharmacogenomics 8, 687-690

33Z. Zhang (2007) Sensitization of calcitonin gene-related peptide receptors by receptor activity-modifying protein-1 in the trigeminal ganglion. Journal of Neuroscience 27, 2693-2703

34E. ter Haar (2010) Crystal structure of the ectodomain complex of the CGRP receptor, a class-B GPCR, reveals the site of drug antagonism. Structure 18, 1083-1093

35S. Hilairet (2001) Agonist-promoted internalization of a ternary complex between calcitonin receptor-like receptor, receptor activity-modifying protein 1 (RAMP1), and beta-arrestin. Journal of Biological Chemistry 276, 42182-42190

36M. Heroux (2007) Functional calcitonin gene-related peptide receptors are formed by the asymmetric assembly of a calcitonin receptor-like receptor homo-oligomer and a monomer of receptor activity-modifying protein-1. Journal of Biological Chemistry 282, 31610-31620

37C.M. Villalon and J. Olesen (2009) The role of CGRP in the pathophysiology of migraine and efficacy of CGRP receptor antagonists as acute antimigraine drugs. Pharmacology & Therapeutics 124, 309-323

38P.J. Goadsby , L. Edvinsson and R. Ekman (1990) Vasoactive peptide release in the extracerebral circulation of humans during migraine headache. Annals of Neurology 28, 183-187

39G. Juhasz (2003) NO-induced migraine attack: strong increase in plasma calcitonin gene-related peptide (CGRP) concentration and negative correlation with platelet serotonin release. Pain 106, 461-470

40V. Gallai (1995) Vasoactive peptide levels in the plasma of young migraine patients with and without aura assessed both interictally and ictally. Cephalalgia 15, 384-390

42J.F. Tvedskov (2005) No increase of calcitonin gene-related peptide in jugular blood during migraine. Annals of Neurology 58, 561-568

43P. Tfelt-Hansen and H. Le (2009) Calcitonin gene-related peptide in blood: is it increased in the external jugular vein during migraine and cluster headache? A review. Journal of Headache and Pain 10, 137-143

44J.L. Bellamy , R.K. Cady and P.L. Durham (2006) Salivary levels of CGRP and VIP in rhinosinusitis and migraine patients. Headache 46, 24-33

45R.K. Cady (2009) Elevated saliva calcitonin gene-related peptide levels during acute migraine predict therapeutic response to rizatriptan. Headache 49, 1258-1266

46J.M. Hansen (2010) Calcitonin gene-related peptide triggers migraine-like attacks in patients with migraine with aura. Cephalalgia 30, 1179-1186

47L.H. Lassen (2002) CGRP may play a causative role in migraine. Cephalalgia 22, 54-61

48M.S. Asghar (2011) Evidence for a vascular factor in migraine. Annals of Neurology 69, 635-645

49J.M. Hansen (2008) Familial hemiplegic migraine type 2 does not share hypersensitivity to nitric oxide with common types of migraine. Cephalalgia 28, 367-375

50J.M. Hansen (2011) Calcitonin gene-related peptide does not cause migraine attacks in patients with familial hemiplegic migraine. Headache 51, 544-553

51R.A. Ophoff (1996) Familial hemiplegic migraine and episodic ataxia type-2 are caused by mutations in the Ca2+ channel gene CACNL1A4. Cell 87, 543-552

52M. De Fusco (2003) Haploinsufficiency of ATP1A2 encoding the Na+ /K+ pump alpha2 subunit associated with familial hemiplegic migraine type 2. Nature Genetics 33, 192-196

53M. Dichgans (2005) Mutation in the neuronal voltage-gated sodium channel SCN1A in familial hemiplegic migraine. Lancet 366, 371-377

54G. Juhasz (2005) Sumatriptan causes parallel decrease in plasma calcitonin gene-related peptide (CGRP) concentration and migraine headache during nitroglycerin induced migraine attack. Cephalalgia 25, 179-183

55J. Olesen (2004) Calcitonin gene-related peptide receptor antagonist BIBN 4096 BS for the acute treatment of migraine. New England Journal of Medicine 350, 1104-1110

56K.M. Connor (2009) Randomized, controlled trial of telcagepant for the acute treatment of migraine. Neurology 73, 970-977

57T.W. Ho (2008) Randomized controlled trial of an oral CGRP receptor antagonist, MK-0974, in acute treatment of migraine. Neurology 70, 1304-1312

60T.W. Ho , L. Edvinsson and P.J. Goadsby (2010) CGRP and its receptors provide new insights into migraine pathophysiology. Nature Reviews Neurology 6, 573-582

61V.S. Seybold (2009) The role of peptides in central sensitization. In Handbook of Experimental Pharmacology, Ed: B.J. Canning and D. Spina , Springer-Vertag, Berlin & Heidelberg, 194, pp. 451-491

62A. Ebersberger (2000) Differential effects of calcitonin gene-related peptide and calcitonin gene-related peptide 8-37 upon responses to N-methyl-D-aspartate or (R, S)-alpha-amino-3-hydroxy-5-methylisoxazole-4-propionate in spinal nociceptive neurons with knee joint input in the rat. Neuroscience 99, 171-178

63X.L. Gu and L.C. Yu (2007) The colocalization of CGRP receptor and AMPA receptor in the spinal dorsal horn neuron of rat: a morphological and electrophysiological study. Neuroscience Letters 414, 237-241

64S. Menon (2011) Association study of calcitonin gene-related polypeptide-alpha (CALCA) gene polymorphism with migraine. Brain Research 1378, 119-124

65V. Anttila (2010) Genome-wide association study of migraine implicates a common susceptibility variant on 8q22.1. Nature Genetics 42, 869-873

66H.K. Iversen , J. Olesen and P. Tfelt-Hansen (1989) Intravenous nitroglycerin as an experimental model of vascular headache. Basic characteristics. Pain 38, 17-24

67I. Christiansen (1999) Glyceryl trinitrate induces attacks of migraine without aura in sufferers of migraine with aura. Cephalalgia 19, 660-667; discussion 626

68L.H. Lassen , L.L. Thomsen and J. Olesen (1995) Histamine induces migraine via the H1-receptor. Support for the NO hypothesis of migraine. Neuroreport 6, 1475-1479

69H.W. Schytz (2009) PACAP38 induces migraine-like attacks in patients with migraine without aura. Brain 132, 16-25

72J. McCulloch (1986) Calcitonin gene-related peptide: functional role in cerebrovascular regulation. Proceedings of the National Academy of Sciences USA 83, 5731-5735

73J. Olesen (2009) Origin of pain in migraine: evidence for peripheral sensitisation. Lancet Neurology 8, 679-690

74K.Y. Chan (2011) Potential mechanisms of prospective antimigraine drugs: a focus on vascular (side) effects. Pharmacology & Therapeutics 129, 332-351

75H.C. Diener (2003) RPR100893, a substance-P antagonist, is not effective in the treatment of migraine attacks. Cephalalgia 23, 183-185

76M.L. Sixt , K. Messlinger and M.J. Fischer (2009) Calcitonin gene-related peptide receptor antagonist olcegepant acts in the spinal trigeminal nucleus. Brain 132, 3134-3141

77L. Edvinsson (2008) CGRP blockers in migraine therapy: where do they act? British Journal of Pharmacology 155, 967-969

78P. Tfelt-Hansen and J. Olesen (2011) Possible site of action of CGRP antagonists in migraine. Cephalalgia 31, 748-750

79M. Lambracht-Hall , V. Dimitriadou and T.C. Theoharides (1990) Migration of mast cells in the developing rat brain. Brain Research Developmental Brain Research 56, 151-159

80J. Wedemeyer , M. Tsai and S.J. Galli (2000) Roles of mast cells and basophils in innate and acquired immunity. Current Opinion of Immunology 12, 624-631

81K. Hakim-Rad , M. Metz and M. Maurer (2009) Mast cells: makers and breakers of allergic inflammation. Current Opinion in Allergy and Clinical Immunology 9, 427-430

82C. Prussin and D.D. Metcalfe (2003) IgE, mast cells, basophils, and eosinophils. Journal of Allergy and Clinical Immunology 111, S486-S494

83N.C. Low and K.R. Merikangas (2003) The comorbidity of migraine. CNS Spectrums 8, 433-434, 437-444

85J.K. Warnock and A.H. Clayton (2003) Chronic episodic disorders in women. Psychiatric Clinics of North America 26, 725-740

86T.C. Theoharides (1983) Mast cells and migraines. Perspectives in Biology and Medicine 26, 672-675

88T.C. Theoharides and D. Kalogeromitros (2006) The critical role of mast cells in allergy and inflammation. Annals of the New York Academy of Science 1088, 78-99

89J.J. Rozniecki (1999) Morphological and functional demonstration of rat dura mater mast cell-neuron interactions in vitro and in vivo. Brain Research 849, 1-15

90R. Burstein , B. Collins and M. Jakubowski (2004) Defeating migraine pain with triptans: a race against the development of cutaneous allodynia. Annals of Neurology 55, 19-26

92E.J. Bowen (2006) Tumor necrosis factor-alpha stimulation of calcitonin gene-related peptide expression and secretion from rat trigeminal ganglion neurons. Journal of Neurochemistry 96, 65-77

93D. Levy (2007) Mast cell degranulation activates a pain pathway underlying migraine headache. Pain 130, 166-176

94A.M. Strassman and D. Levy (2006) Response properties of dural nociceptors in relation to headache. Journal of Neurophysiology 95, 1298-1306

95C. Waeber and M.A. Moskowitz (2005) Migraine as an inflammatory disorder. Neurology 64, S9-15

96J.M. Launay (1987) Histamine-release and migraine. Revue de Médecine Interne 8, 273-275

97R.V. Heatley (1982) Increased plasma histamine levels in migraine patients. Clinical Allergy 12, 145-149

98O. Sjaastad and O.V. Sjaastad (1977) Histamine metabolism in cluster headache and migraine. Catabolism of 14C histamine. Journal of Neurology 216, 105-117

99A.A. Krabbe and J. Olesen (1980) Headache provocation by continuous intravenous infusion of histamine. Clinical results and receptor mechanisms. Pain 8, 253-259

100L.H. Lassen (1996) Histamine inhalation is a specific but insensitive laboratory test for migraine. Cephalalgia 16, 550-553

101N. Schwenger (2007) Interaction of calcitonin gene-related peptide, nitric oxide and histamine release in neurogenic blood flow and afferent activation in the rat cranial dura mater. Cephalalgia 27, 481-491

102L.H. Lassen (1996) Histamine-1 receptor blockade does not prevent nitroglycerin induced migraine. Support for the NO-hypothesis of migraine. European Journal of Clinical Pharmacology 49, 335-339

104D.W. Lewis (2004) Prophylactic treatment of pediatric migraine. Headache 44, 230-237

105M. Togha , H. Ashrafian and P. Tajik (2006) Open-label trial of cinnarizine in migraine prophylaxis. Headache 46, 498-502

106H.C. Diener (2006) Aspirin in the treatment of acute migraine attacks. Expert Review of Neurotherapeutics 6, 563-573

107S.D. Silberstein and P.J. Goadsby (2002) Migraine: preventive treatment. Cephalalgia 22, 491-512

109F. Sheftell (2000) Montelukast in the prophylaxis of migraine: a potential role for leukotriene modifiers. Headache 40, 158-163

110de Souza, D. Carvalho (2002) Asthma plus migraine in childhood and adolescence: prophylactic benefits with leukotriene receptor antagonist. Headache 42, 1044-1047

111J.L. Brandes (2004) Montelukast for migraine prophylaxis: a randomized, double-blind, placebo-controlled study. Headache 44, 581-586

112A. Clemons (2011) Amitriptyline and prochlorperazine inhibit proinflammatory mediator release from human mast cells: possible relevance to chronic fatigue syndrome. Journal of Clinical Psychopharmacology 31, 385-387

114E. Hansson and L. Ronnback (2003) Glial neuronal signaling in the central nervous system. FASEB Journal 17, 341-348

115M. Eberhardt (2009) Glyceroltrinitrate facilitates stimulated CGRP release but not gene expression of CGRP or its receptor components in rat trigeminal ganglia. Neuropeptides 43, 483-489

116C.V. Vause and P.L. Durham (2010) Calcitonin gene-related peptide differentially regulates gene and protein expression in trigeminal glia cells: findings from array analysis. Neuroscience Letters 473, 163-167

117S. Thalakoti (2007) Neuron-glia signaling in trigeminal ganglion: implications for migraine pathology. Headache 47, 1008-1023; discussion 1024-1005

118A. Capuano (2009) Proinflammatory-activated trigeminal satellite cells promote neuronal sensitization: relevance for migraine pathology. Molecular Pain 5, 43

119A. De Corato (2011) Trigeminal satellite cells express functional calcitonin gene-related peptide receptors, whose activation enhances interleukin-1beta pro-inflammatory effects. Journal of Neuroimmunology J Neuroimmunol. 2011 Aug 15;237(1-2):39-46

120L.R. Watkins , E.D. Milligan and S.F. Maier (2001) Spinal cord glia: new players in pain. Pain 93, 201-205

121H. Cao and Y.Q. Zhang (2008) Spinal glial activation contributes to pathological pain states. Neuroscience and Biobehavioral Review 32, 972-983

122A. Recober (2009) Role of calcitonin gene-related peptide in light-aversive behavior: implications for migraine. Journal of Neuroscience 29, 8798-8804

124S.G. Amara (1982) Alternative RNA processing in calcitonin gene expression generates mRNAs encoding different polypeptide products. Nature 298, 240-244

125F. Moya , A. Nieto and R.C. JL (1975) Calcitonin biosynthesis: evidence for a precursor. European Journal of Biochemistry/FEBS 55, 407-413

126K.Y. Park (2011) Epigenetic regulation of the calcitonin gene-related peptide gene in trigeminal glia. Cephalalgia 31, 614-624

127K.A. Kristiansen and L. Edvinsson (2010) Neurogenic inflammation: a study of rat trigeminal ganglion. Journal of Headache and Pain 11, 485-495

128J. Tajti (2011) Organ culture of the trigeminal ganglion induces enhanced expression of calcitonin gene-related peptide via activation of extracellular signal-regulated protein kinase 1/2. Cephalalgia 31, 95-105

129I. Buhaescu , R.A. Yood and H. Izzedine (2010) Serum procalcitonin in systemic autoimmune diseases – where are we now? Seminars in Arthritis and Rheumatism 40, 176-183

130J.M. Martinez (2001) Late immunoneutralization of procalcitonin arrests the progression of lethal porcine sepsis. Surgical Infection (Larchmt) 2, 193-202; discussion 202-193

132P.M. Sexton (2008) Procalcitonin has bioactivity at calcitonin receptor family complexes: potential mediator implications in sepsis. Critical Care Medicine 36, 1637-1640

133J. Olesen , B. Larsen and M. Lauritzen (1981) Focal hyperemia followed by spreading oligemia and impaired activation of rCBF in classic migraine. Annals of Neurology 9, 344-352

134M. Lauritzen (1994) Pathophysiology of the migraine aura. The spreading depression theory. Brain 117(Pt 1), 199-210

135N. Hadjikhani (2001) Mechanisms of migraine aura revealed by functional MRI in human visual cortex. Proceedings of the National of Academy Science USA 98, 4687-4692

136C. Ayata (2006) Suppression of cortical spreading depression in migraine prophylaxis. Annals of Neurology 59, 652-661

137J. Wolthausen (2009) Are cortical spreading depression and headache in migraine causally linked? Cephalalgia 29, 244-249

138A.W. Hauge (2009) Effects of tonabersat on migraine with aura: a randomised, double-blind, placebo-controlled crossover study. Lancet Neurology 8, 718-723

140M. Wahl (1994) Involvement of calcitonin gene-related peptide (CGRP) and nitric oxide (NO) in the pial artery dilatation elicited by cortical spreading depression. Brain Research 637, 204-210

141R.D. Piper (1993) Cortical spreading depression does not result in the release of calcitonin gene-related peptide into the external jugular vein of the cat: relevance to human migraine. Cephalalgia 13, 180-183; discussion 149

142H. Bolay (2002) Intrinsic brain activity triggers trigeminal meningeal afferents in a migraine model. Nature Medicine 8, 136-142

143X. Zhang (2010) Activation of meningeal nociceptors by cortical spreading depression: implications for migraine with aura. Journal of Neuroscience 30, 8807-8814

144X. Zhang (2011) Activation of central trigeminovascular neurons by cortical spreading depression. Annals of Neurology 69, 855-865

146P.E. Kunkler and R.P. Kraig (2003) Hippocampal spreading depression bilaterally activates the caudal trigeminal nucleus in rodents. Hippocampus 13, 835-844

147M.G. Buzzi , M. Bonamini and M.A. Moskowitz (1995) Neurogenic model of migraine. Cephalalgia 15, 277-280

148M. Jakubowski (2007) Sensitization of central trigeminovascular neurons: blockade by intravenous naproxen infusion. Neuroscience 148, 573-583

149X.C. Zhang (2011) Tumor necrosis factor-alpha induces sensitization of meningeal nociceptors mediated via local COX and p38 MAP kinase actions. Pain 152, 140-149

150R. Noseda (2010) Changes of meningeal excitability mediated by corticotrigeminal networks: a link for the endogenous modulation of migraine pain. Journal of Neuroscience 30, 14420-14429

151R.M. Edelmayer (2009) Medullary pain facilitating neurons mediate allodynia in headache-related pain. Annals of Neurology 65, 184-193

152A. Dobolyi (2005) Calcitonin gene-related peptide-containing pathways in the rat forebrain. Journal of Comparative Neurology 489, 92-119

153G. Skofitsch and D.M. Jacobowitz (1985) Autoradiographic distribution of 125I calcitonin gene-related peptide binding sites in the rat central nervous system. Peptides 6, 975-986

154K. Yashpal (1992) Quantitative autoradiographic distribution of calcitonin gene-related peptide (hCGRP alpha) binding sites in the rat and monkey spinal cord. Journal of Comparative Neurology 322, 224-232

156R. Noseda and R. Burstein (2011) Advances in understanding the mechanisms of migraine-type photophobia. Current Opinion in Neurology 24, 197-202

157K. Okamoto (2010) Bright light activates a trigeminal nociceptive pathway. Pain 149, 235-242

158G. Selby and J.W. Lance (1960) Observations on 500 cases of migraine and allied vascular headache. Journal of Neurology, Neurosurgery & Psychiatry 23, 23-32

159P.D. Drummond (1986) A quantitative assessment of photophobia in migraine and tension headache. Headache 26, 465-469

160M.S. Freedman (1999) Regulation of mammalian circadian behavior by non-rod, non-cone, ocular photoreceptors. Science 284, 502-504

161S.K. Afridi (2005) A positron emission tomographic study in spontaneous migraine. Archives of Neurology 62, 1270-1275

164A. Kresse , D.M. Jacobowitz and G. Skofitsch (1995) Detailed mapping of CGRP mRNA expression in the rat central nervous system: comparison with previous immunocytochemical findings. Brain Research Bulletin 36, 261-274

165O. Summ (2010) Modulation of nocioceptive transmission with calcitonin gene-related peptide receptor antagonists in the thalamus. Brain 133, 2540-2548

166C. Gauriau and J.F. Bernard (2004) Posterior triangular thalamic neurons convey nociceptive messages to the secondary somatosensory and insular cortices in the rat. Journal of Neuroscience 24, 752-761

167S. de Lacalle and C.B. Saper (2000) Calcitonin gene-related peptide-like immunoreactivity marks putative visceral sensory pathways in human brain. Neuroscience 100, 115-130

168Y. Yasui , C.B. Saper and D.F. Cechetto (1991) Calcitonin gene-related peptide (CGRP) immunoreactive projections from the thalamus to the striatum and amygdala in the rat. Journal of Comparative Neurology 308, 293-310

169S. Campeau and S.J. Watson Jr., (2000) Connections of some auditory-responsive posterior thalamic nuclei putatively involved in activation of the hypothalamo–pituitary–adrenocortical axis in response to audiogenic stress in rats: an anterograde and retrograde tract tracing study combined with Fos expression. Journal of Comparative Neurology 423, 474-491

170L.M. Coolen (2003) Parvocellular subparafascicular thalamic nucleus in the rat: anatomical and functional compartmentalization. Journal of Comparative Neurology 463, 117-131

171L.M. Coolen (2003) Afferent connections of the parvocellular subparafascicular thalamic nucleus in the rat: evidence for functional subdivisions. Journal of Comparative Neurology 463, 132-156

172W. Ma (2003) Localization and modulation of calcitonin gene-related peptide-receptor component protein-immunoreactive cells in the rat central and peripheral nervous systems. Neuroscience 120, 677-694

173L. Edvinsson (2011) Cerebellar distribution of calcitonin gene-related peptide (CGRP) and its receptor components calcitonin receptor-like receptor (CLR) and receptor activity modifying protein 1 (RAMP1) in rat. Molecular and Cellular Neuroscience 46, 333-339

174S. Hattar (2006) Central projections of melanopsin-expressing retinal ganglion cells in the mouse. Journal of Comparative Neurology 497, 326-349

175B. Calvino and R.M. Grilo (2006) Central pain control. Joint Bone Spine 73, 10-16

176H.M. Cooper (1994) Neuroanatomical pathways linking vision and olfaction in mammals. Psychoneuroendocrinology 19, 623-639

177A.S. Elliott , M.L. Weiss and A.A. Nunez (1995) Direct retinal communication with the peri-amygdaloid area. Neuroreport 6, 806-808

178L.P. Morin and J.H. Blanchard (1999) Forebrain connections of the hamster intergeniculate leaflet: comparison with those of ventral lateral geniculate nucleus and retina. Visual Neuroscience 16, 1037-1054

179K.S. Sink (2011) Calcitonin gene-related peptide in the bed nucleus of the stria terminalis produces an anxiety-like pattern of behavior and increases neural activation in anxiety-related structures. Journal of Neuroscience 31, 1802-1810

180W. D'Hanis , R. Linke and D.M. Yilmazer-Hanke (2007) Topography of thalamic and parabrachial calcitonin gene-related peptide (CGRP) immunoreactive neurons projecting to subnuclei of the amygdala and extended amygdala. Journal of Comparative Neurology 505, 268-291

181G.F. Gebhart (2004) Descending modulation of pain. Neuroscience & Biobehavioral Review 27, 729-737

182M.M. Behbehani (1995) Functional characteristics of the midbrain periaqueductal gray. Progress in Neurobiology 46, 575-605

183E. Thiels , E.K. Hoffman and M.B. Gorin (2008) A reliable behavioral assay for the assessment of sustained photophobia in mice. Current Eye Research 33, 483-491

185A. Recober (2010) Induction of multiple photophobic behaviors in a transgenic mouse sensitized to CGRP. Neuropharmacology 58, 156-165

187H.C. Diener (2011) BI 44370 TA, an oral CGRP antagonist for the treatment of acute migraine attacks: results from a phase II study. Cephalalgia 31, 573-584

188D.J. Hewitt (2011) Randomized controlled trial of the CGRP receptor antagonist MK-3207 in the acute treatment of migraine. Cephalalgia 31, 712-722

190J. Zeller (2008) CGRP function-blocking antibodies inhibit neurogenic vasodilatation without affecting heart rate or arterial blood pressure in the rat. British Journal of Pharmacology 155, 1093-1103

191C.N. Sang (2004) LY293558, a novel AMPA/GluR5 antagonist, is efficacious and well-tolerated in acute migraine. Cephalalgia 24, 596-602

R. Noseda , (2010) A neural mechanism for exacerbation of headache by light. Nature Neuroscience 13, 239-245

Recommend this journal

Email your librarian or administrator to recommend adding this journal to your organisation's collection.

Expert Reviews in Molecular Medicine
  • ISSN: -
  • EISSN: 1462-3994
  • URL: /core/journals/expert-reviews-in-molecular-medicine
Please enter your name
Please enter a valid email address
Who would you like to send this to? *
×